Search research articles
Contact Us
Filters
Showing results (1-10 of 39) with videos related to
Page
of 4
Sort By:
Journal of Clinical Lipidology
|
May 7, 2013
Emerging low-density lipoprotein (LDL) therapies: Management of severely elevated LDL cholesterol--the role of LDL-apheresis
Mary P McGowan
Circulation
|
October 13, 2004
There is no evidence for an increase in acute coronary syndromes after short-term abrupt discontinuation of statins in stable cardiac patients
Mary P McGowan,
Current Treatment Options in Cardiovascular Medicine
|
May 13, 2011
Polycystic ovary syndrome: a common endocrine disorder and risk factor for vascular disease
Mary P McGowan
Lancet (London, England)
|
September 10, 2021
Familial hypercholesterolaemia: too many lost opportunities
Marina Cuchel, Mary P McGowan
Current Atherosclerosis Reports
|
October 27, 2009
Nutritional supplements and serum lipids: does anything work?
Mary P McGowan, Suzanne Proulx
Lancet (London, England)
|
December 15, 2023
Universal paediatric screening for familial hypercholesterolaemia
Mary P McGowan, Marina Cuchel
The Journal of Pediatrics
|
February 2, 2024
Universal Pediatric Cholesterol Screening: The Time Has Come!
Mary P McGowan, Amy L Peterson
JAMA
|
November 28, 2023
USPSTF Recommendation on Screening for Lipid Disorders in Children and Adolescents
Mary P McGowan, Marina Cuchel, Paul C Lee
Journal of Clinical Lipidology
|
May 24, 2011
Management of familial hypercholesterolemias in adult patients: recommendations from the National Lipid Association Expert Panel on Familial Hypercholesterolemia
Matthew K Ito, Mary P McGowan, Patrick M Moriarty, et al.
American Heart Journal Plus : Cardiology Research and Practice
|
March 21, 2024
Lipoprotein(a): An important piece of the ASCVD risk factor puzzle across diverse populations
Nicole Ciffone, Catherine J McNeal, Mary P McGowan, et al.
Page
of 4
Search research articles
Search
Showing results (1-10 of 39) with videos related to
Sort By:
Page
of 4
Journal of Clinical Lipidology
|
May 7, 2013
Emerging low-density lipoprotein (LDL) therapies: Management of severely elevated LDL cholesterol--the role of LDL-apheresis
Mary P McGowan
Circulation
|
October 13, 2004
There is no evidence for an increase in acute coronary syndromes after short-term abrupt discontinuation of statins in stable cardiac patients
Mary P McGowan,
Current Treatment Options in Cardiovascular Medicine
|
May 13, 2011
Polycystic ovary syndrome: a common endocrine disorder and risk factor for vascular disease
Mary P McGowan
Lancet (London, England)
|
September 10, 2021
Familial hypercholesterolaemia: too many lost opportunities
Marina Cuchel, Mary P McGowan
Current Atherosclerosis Reports
|
October 27, 2009
Nutritional supplements and serum lipids: does anything work?
Mary P McGowan, Suzanne Proulx
Lancet (London, England)
|
December 15, 2023
Universal paediatric screening for familial hypercholesterolaemia
Mary P McGowan, Marina Cuchel
The Journal of Pediatrics
|
February 2, 2024
Universal Pediatric Cholesterol Screening: The Time Has Come!
Mary P McGowan, Amy L Peterson
JAMA
|
November 28, 2023
USPSTF Recommendation on Screening for Lipid Disorders in Children and Adolescents
Mary P McGowan, Marina Cuchel, Paul C Lee
Journal of Clinical Lipidology
|
May 24, 2011
Management of familial hypercholesterolemias in adult patients: recommendations from the National Lipid Association Expert Panel on Familial Hypercholesterolemia
Matthew K Ito, Mary P McGowan, Patrick M Moriarty, et al.
American Heart Journal Plus : Cardiology Research and Practice
|
March 21, 2024
Lipoprotein(a): An important piece of the ASCVD risk factor puzzle across diverse populations
Nicole Ciffone, Catherine J McNeal, Mary P McGowan, et al.
Page
of 4